Relmada Therapeutics, Inc.

DEUTSCHE BANK AG\ RLMD

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/11/2026

Shares

224,846

Value ($000)

1,086

Weight

0.0%

2020 Q2 - 2025 Q4 (23 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/11/2026	1,086	0.0%	224,846	12/31/2025
2025 Q3	11/13/2025	452	0.0%	224,846	9/30/2025
2025 Q2	8/12/2025	135	0.0%	224,846	6/30/2025
2025 Q1	5/9/2025	61	0.0%	224,846	3/31/2025
2024 Q4	6/30/2025	117	0.0%	224,846	12/31/2024
2024 Q3	6/26/2025	729	0.0%	224,846	9/30/2024
2024 Q2	6/12/2025	675	0.0%	224,846	6/30/2024
2024 Q1	6/2/2025	1,046	0.0%	224,846	3/31/2024
2023 Q4	2/14/2024	931	0.0%	224,846	12/31/2023
2023 Q3	11/24/2023	15	0.0%	4,959	9/30/2023
2023 Q2	8/14/2023	586	0.0%	238,297	6/30/2023
2023 Q1	5/15/2023	576	0.0%	254,742	3/31/2023
2022 Q4	2/13/2023	835	0.0%	239,175	12/31/2022
2022 Q3	11/14/2022	8,785	0.0%	237,306	9/30/2022
2022 Q2	8/11/2022	4,541	0.0%	239,133	6/30/2022
2022 Q1	5/13/2022	6,439	0.0%	238,573	3/31/2022
2021 Q4	2/16/2022	229	0.0%	10,159	12/31/2021
2021 Q3	11/4/2021	432	0.0%	16,481	9/30/2021
2021 Q2	8/11/2021	501	0.0%	15,661	6/30/2021
2021 Q1	5/13/2021	563	0.0%	16,018	3/31/2021
2020 Q4	2/16/2021	371	0.0%	11,607	12/31/2020
2020 Q3	11/12/2020	294	0.0%	7,817	9/30/2020
2020 Q2	8/13/2020	320	0.0%	7,136	6/30/2020